HES1 and familial pancreatic carcinoma: In the current study, QYHJ could prolong the survival time and decrease expression of Notch-targeted genes Hes-1 and Hey-1, indicating that downregulating main target genes in Notch signaling pathway might be its potential mechanism for improvement of survival in pancreatic cancer.